Bosco A. Paes
Hamilton, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 126 publications
Palivizumab for respiratory syncytial virus immunoprophylaxis in high-risk populations in Qatar: a call for action.
Journal: Expert review of anti-infective therapy
Published: July 20, 2026
Meta-analysis of the efficacy of palivizumab versus nirsevimab at preventing medically attended respiratory syncytial virus infections in non-hospitalized preterm infants.
Journal: Human vaccines & immunotherapeutics
Published: April 01, 2026
Successes, lessons learned and recommendations for the future: Experiences from the first year of Ontario's nirsevimab program for respiratory syncytial virus (RSV) prophylaxis in infants.
Journal: Human vaccines & immunotherapeutics
Published: September 12, 2025
Respiratory syncytial virus immunization in children: The old, the new and what's just around the corner.
Journal: Human vaccines & immunotherapeutics
Published: June 24, 2025
Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children.
Journal: Expert review of anti-infective therapy
Published: March 20, 2025
Cost-effectiveness of wastewater and environmental monitoring of respiratory syncytial virus to guide universal infant immunoprophylaxis in Canada.
Journal: Journal of medical economics
Published: February 28, 2025
Systematic Review and Expert Consensus on the Use of Long-acting Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Disease: ARMADA (Advancing RSV Management And Disease Awareness) Taskforce.
Journal: Open forum infectious diseases
Published: February 19, 2025
Clinical and economic evaluation of risk factor guided respiratory syncytial virus prophylaxis in Colombian preterm infants.
Journal: Cost effectiveness and resource allocation : C/E
Published: February 11, 2025
Optimal implementation of an Ontario nirsevimab program for respiratory syncytial virus (RSV) prophylaxis: Recommendations from a provincial RSV expert panel.
Journal: Human vaccines & immunotherapeutics
Published: December 18, 2024
Optimizing risk factors to guide COST-effective use of palivizumab in KOREAN infants.
Journal: Pediatrics international : official journal of the Japan Pediatric Society
Published: April 29, 2024
A prospective evaluation of tibial insertion sites for intraosseous needles to gain vascular access in Asian neonates.
Journal: Journal of perinatology : official journal of the California Perinatal Association
Published: April 15, 2024
Last Updated: 09/26/2026